Investors |


1 March 2018

LexaGene appoints Jeffrey Mitchell as Chief Financial Officer of the Company. Mr. Mitchell has over two decades of financial and SEC experience.

Read More

22 February 2018

LexaGene honored as a Top 50-Ranked TSX Venture company, ranked by share price, trading volume and market capitalization.

Read More

6 February 2018

LexaGene leases larger space to support company growth. The Company has significantly expanded its operations and made key new hires.

Read More